Latest filing published 13 Feb 2024 for Palisade Bio, INC..
Insider track record
No signal scores available.
Cristina Csimma: trading record in brief
Filings by Cristina Csimma span 2 companies, the busiest being Juniper Pharmaceuticals Inc and Palisade Bio, Inc. Between 3 May 2011 and 8 February 2024, the trades on record add up to 11 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 13 February 2024, the filings show an option exercise in Palisade Bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Cristina Csimma
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,820 shares0Common Stock, par value $0.01SEC:0001493152-24-006047:1
- 6,980 shares0Common Stock, par value $0.01SEC:0001493152-24-006047:0
- 36,109 shares@ US$11.50100.0% of flowCommon StockSEC:0001209191-18-046804:0
- 8,910 shares0Common Stock, par value $0.01SEC:0001209191-17-043437:0
- 6,064 shares0common stock, par value $0.01SEC:0001382963-16-000217:0
- 2,529 shares0common stock, par value $0.01SEC:0001382963-15-000124:0
- 2,117 shares@ US$6.57$.01 Par Value Common StockSEC:0001181431-14-019302:1
7 of 7 declarations